ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)

Recruiting now · Phase 4

Conditions studied: Vasodilatory Hypotension During or After Cardiac Surgery

In brief

The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.

Key facts

Study ID
NCT06487585
Run by
University of Maryland St. Joseph Medical Center
People needed
100
Starts
2025-05-06
Expected to finish
2026-02-01
Last updated by the study team
2025-12-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.